Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Ebdarokimab (Anti-IL-12b) For research use only.
Not for use in humans.

Ebdarokimab (Anti-IL-12b)

Synonyms:

Ebdarokimab (Anti-IL-12b) is a fully human monoclonal antibody (mAb) targeting Interleukin-12/Interleukin-23 (IL-12/IL-23) pathway. Ebdarokimab has the potential to treat moderate to severe plaque psoriasis. MW : 145.6 KD.

Ebdarokimab (Anti-IL-12b)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Ebdarokimab (Anti-IL-12b) is a fully human monoclonal antibody (mAb) targeting Interleukin-12/Interleukin-23 (IL-12/IL-23) pathway. Ebdarokimab has the potential to treat moderate to severe plaque psoriasis. MW : 145.6 KD.

Product Details

CAS No. 2393651-11-9
Molecular Weight 145.6
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ebdarokimab (Anti-IL-12b) | Ebdarokimab (Anti-IL-12b) supplier | purchase Ebdarokimab (Anti-IL-12b) | Ebdarokimab (Anti-IL-12b) cost | Ebdarokimab (Anti-IL-12b) manufacturer | order Ebdarokimab (Anti-IL-12b) | Ebdarokimab (Anti-IL-12b) distributor